| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-74210 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-70407 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-66539-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-65336-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB120-2737-50ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-41296-0.025mg | |||
![Western Blot: SLA2 Antibody (3A7) [NBP2-45867] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SLA2.](http://images.novusbio.com/fullsize/SLA2-Antibody-3A7-Western-Blot-NBP2-45867-img0016.jpg "Western Blot: SLA2 Antibody (3A7) [NBP2-45867] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY SLA2.")
![Immunohistochemistry: SLA2 Antibody (3A7) [NBP2-45867] - Analysis of Human lung tissue.](http://images.novusbio.com/fullsize/SLA2-Antibody-3A7-Immunohistochemistry-NBP2-45867-img0015.jpg)
![Flow Cytometry: SLA2 Antibody (3A7) [NBP2-45867] - Analysis of HEK293T cells transfected with either overexpress plasmid(Red) or empty vector control plasmid(Blue) were immunostained by SLA2 antibody.](http://images.novusbio.com/fullsize/SLA2-Antibody-3A7-Flow-Cytometry-NBP2-45867-img0001.jpg)
![Immunohistochemistry: SLA2 Antibody (3A7) [NBP2-45867] - Analysis of Carcinoma of Human thyroid tissue.](http://images.novusbio.com/fullsize/SLA2-Antibody-3A7-Immunohistochemistry-NBP2-45867-img0002.jpg)
![Immunohistochemistry: SLA2 Antibody (3A7) [NBP2-45867] - Analysis of Carcinoma of Human kidney tissue.](http://images.novusbio.com/fullsize/SLA2-Antibody-3A7-Immunohistochemistry-NBP2-45867-img0003.jpg)
![Immunohistochemistry: SLA2 Antibody (3A7) [NBP2-45867] - Analysis of Human breast tissue.](http://images.novusbio.com/fullsize/SLA2-Antibody-3A7-Immunohistochemistry-NBP2-45867-img0004.jpg)
![Immunohistochemistry: SLA2 Antibody (3A7) [NBP2-45867] - Analysis of Adenocarcinoma of Human breast tissue.](http://images.novusbio.com/fullsize/SLA2-Antibody-3A7-Immunohistochemistry-NBP2-45867-img0005.jpg)
![Immunohistochemistry: SLA2 Antibody (3A7) [NBP2-45867] - Analysis of Adenocarcinoma of Human endometrium tissue.](http://images.novusbio.com/fullsize/SLA2-Antibody-3A7-Immunohistochemistry-NBP2-45867-img0006.jpg)
![Immunohistochemistry: SLA2 Antibody (3A7) [NBP2-45867] - Analysis of Carcinoma of Human prostate tissue.](http://images.novusbio.com/fullsize/SLA2-Antibody-3A7-Immunohistochemistry-NBP2-45867-img0007.jpg)
![Immunohistochemistry: SLA2 Antibody (3A7) [NBP2-45867] - Analysis of Adenocarcinoma of Human colon tissue.](http://images.novusbio.com/fullsize/SLA2-Antibody-3A7-Immunohistochemistry-NBP2-45867-img0008.jpg)
![Immunohistochemistry: SLA2 Antibody (3A7) [NBP2-45867] - Analysis of Human pancreas tissue.](http://images.novusbio.com/fullsize/SLA2-Antibody-3A7-Immunohistochemistry-NBP2-45867-img0009.jpg)
![Immunohistochemistry: SLA2 Antibody (3A7) [NBP2-45867] - Analysis of Human Kidney tissue.](http://images.novusbio.com/fullsize/SLA2-Antibody-3A7-Immunohistochemistry-NBP2-45867-img0010.jpg)
![Immunohistochemistry: SLA2 Antibody (3A7) [NBP2-45867] - Analysis of Human colon tissue.](http://images.novusbio.com/fullsize/SLA2-Antibody-3A7-Immunohistochemistry-NBP2-45867-img0011.jpg)
![Immunohistochemistry: SLA2 Antibody (3A7) [NBP2-45867] - Analysis of Human prostate tissue.](http://images.novusbio.com/fullsize/SLA2-Antibody-3A7-Immunohistochemistry-NBP2-45867-img0012.jpg)
![Immunohistochemistry: SLA2 Antibody (3A7) [NBP2-45867] - Analysis of Human bladder tissue.](http://images.novusbio.com/fullsize/SLA2-Antibody-3A7-Immunohistochemistry-NBP2-45867-img0013.jpg)
![Immunohistochemistry: SLA2 Antibody (3A7) [NBP2-45867] - Analysis of Adenocarcinoma of Human ovary tissue.](http://images.novusbio.com/fullsize/SLA2-Antibody-3A7-Immunohistochemistry-NBP2-45867-img0014.jpg)
![Western Blot: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CEACAM-5.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Western-Blot-NBP2-46231-img0018.jpg "Western Blot: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CEACAM-5.")
![Immunohistochemistry: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of Human tonsil tissue.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Immunohistochemistry-NBP2-46231-img0017.jpg)
![Immunohistochemistry: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of Human colon tissue.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Immunohistochemistry-NBP2-46231-img0001.jpg)
![Immunohistochemistry: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of Human Kidney tissue.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Immunohistochemistry-NBP2-46231-img0002.jpg)
![Immunohistochemistry: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of Human liver tissue.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Immunohistochemistry-NBP2-46231-img0003.jpg)
![Immunohistochemistry: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of Carcinoma of Human liver tissue.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Immunohistochemistry-NBP2-46231-img0004.jpg)
![Immunohistochemistry: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of Human lung tissue.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Immunohistochemistry-NBP2-46231-img0005.jpg)
![Immunohistochemistry: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of Carcinoma of Human lung tissue.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Immunohistochemistry-NBP2-46231-img0006.jpg)
![Immunohistochemistry: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of Adenocarcinoma of Human ovary tissue.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Immunohistochemistry-NBP2-46231-img0007.jpg)
![Immunohistochemistry: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of Human pancreas tissue.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Immunohistochemistry-NBP2-46231-img0008.jpg)
![Immunohistochemistry: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of Carcinoma of Human pancreas tissue.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Immunohistochemistry-NBP2-46231-img0009.jpg)
![Immunohistochemistry: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of Human endometrium tissue.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Immunohistochemistry-NBP2-46231-img0010.jpg)
![Immunohistochemistry: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of Human prostate tissue.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Immunohistochemistry-NBP2-46231-img0011.jpg)
![Immunohistochemistry: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of Carcinoma of Human prostate tissue.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Immunohistochemistry-NBP2-46231-img0012.jpg)
![Immunohistochemistry: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of Human bladder tissue.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Immunohistochemistry-NBP2-46231-img0013.jpg)
![Immunohistochemistry: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of Carcinoma of Human bladder tissue.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Immunohistochemistry-NBP2-46231-img0014.jpg)
![Immunohistochemistry: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of Human lymph node tissue.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Immunohistochemistry-NBP2-46231-img0015.jpg)
![Immunohistochemistry: CEACAM-5/CD66e Antibody (3D8) [NBP2-46231] - Analysis of Human lymphoma tissue.](http://images.novusbio.com/fullsize/CEACAM-5-CD66e-Antibody-3D8-Immunohistochemistry-NBP2-46231-img0016.jpg)
![Immunocytochemistry/Immunofluorescence: Complement Component C1qA Antibody (3R9/2) [NB100-64729] - C4d deposition in graft biopsies of patients with DGF. C4d (green, E) co-localized with C1QA (red, G) at peri-tubular capillary sites (merge, I). TO-PRO-3 (blue) was used to stain nuclei. Original magnifications were (E-J) x630.](http://images.novusbio.com/fullsize/Complement-Component-C1qA-Antibody-3R9-2-Immunocytochemistry-Immunofluorescence-NB100-64729-img0006.jpg "Immunocytochemistry/Immunofluorescence: Complement Component C1qA Antibody (3R9/2) [NB100-64729] - C4d deposition in graft biopsies of patients with DGF. C4d (green, E) co-localized with C1QA (red, G) at peri-tubular capillary sites (merge, I). TO-PRO-3 (blue) was used to stain nuclei. Original magnifications were (E-J) x630.")
![Flow Cytometry: Complement Component C1qA Antibody (3R9/2) [NB100-64729]](http://images.novusbio.com/fullsize/Complement-Component-C1qA-Antibody-3R9-2-Flow-Cytometry-NB100-64729-img0007.jpg)
![Immunohistochemistry-Frozen: Complement C3c Antibody (10-02A) [NB100-64339] - Human dermis stained with Complement C3c Antibody. IHC-Fr image submitted by a verified customer review.](http://images.novusbio.com/fullsize/Complement-C3c-Antibody-10-02A-Immunohistochemistry-Frozen-NB100-64339-img0001.jpg "Immunohistochemistry-Frozen: Complement C3c Antibody (10-02A) [NB100-64339] - Human dermis stained with Complement C3c Antibody. IHC-Fr image submitted by a verified customer review.")
![Flow Cytometry: Complement Component C5a R1 Antibody (P12/1) [NB100-66539] - Staining of human peripheral blood granulocytes with MOUSE ANTI HUMAN CD88 (NB100-66539).](http://images.novusbio.com/fullsize/Complement-Component-C5a-R1-Antibody-P12-1-Flow-Cytometry-NB100-66539-img0001.jpg "Flow Cytometry: Complement Component C5a R1 Antibody (P12/1) [NB100-66539] - Staining of human peripheral blood granulocytes with MOUSE ANTI HUMAN CD88 (NB100-66539).")
![Flow Cytometry: Complement Component C5a R1 Antibody (P12/1) [NB100-66539] - Staining of human peripheral blood granulocytes with MOUSE ANTI HUMAN CD88: FITC.](http://images.novusbio.com/fullsize/Complement-Component-C5a-R1-Antibody-P12-1-Flow-Cytometry-NB100-66539-img0003.jpg)
![Flow Cytometry: CD31/PECAM1 Antibody (LCI-4) [NB100-65336] - Staining of porcine peripheral blood lymphocytes.](http://images.novusbio.com/fullsize/CD31-PECAM1-Antibody-LCI-4-Flow-Cytometry-NB100-65336-img0001.jpg "Flow Cytometry: CD31/PECAM1 Antibody (LCI-4) [NB100-65336] - Staining of porcine peripheral blood lymphocytes.")
![Immunocytochemistry/Immunofluorescence: LAP1 Antibody (RL13) [NB120-2737] - Analysis of LAP1 using anti-LAP1 monoclonal antibody shows staining in NS-1 Cells.](http://images.novusbio.com/fullsize/LAP1-Antibody-RL13-Immunocytochemistry-Immunofluorescence-NB120-2737-img0009.jpg "Immunocytochemistry/Immunofluorescence: LAP1 Antibody (RL13) [NB120-2737] - Analysis of LAP1 using anti-LAP1 monoclonal antibody shows staining in NS-1 Cells.")
![Immunohistochemistry-Paraffin: LAP1 Antibody (RL13) [NB120-2737] - Immunohistochemistry was performed on rat lymph node tissue. To expose target protein, antigen was retreived. Endogenous peroxidases were blocked in 3% H202-methanol for 15 minutes and tissues were blocked in 3% BSA-PBS for 30 minutes at room temperature. Cells were probed with a LAP1 mouse monoclonal antibody at a dilution of 1:50 overnight in a humidified chamber. Tissues were washed in PBST and detection was performed. DAB staining buffer was applied and tissues were counterstained with hematoxylin and prepped for mounting.](http://images.novusbio.com/fullsize/LAP1-Antibody-RL13-Immunohistochemistry-Paraffin-NB120-2737-img0008.jpg)
![Immunohistochemistry: LAP1 Antibody (RL13) [NB120-2737] - Immunohistochemistry was performed on rat breast tissue. To expose target protein, antigen was retreived. Endogenous peroxidases were blocked in 3% H202-methanol for 15 minutes and tissues were blocked in 3% BSA-PBS for 30 minutes at room temperature. Cells were probed with a LAP1 mouse monoclonal antibody at a dilution of 1:50 overnight in a humidified chamber. Tissues were washed in PBST and detection was performed. DAB staining buffer was applied and tissues were counterstained with hematoxylin and prepped for mounting.](http://images.novusbio.com/fullsize/LAP1-Antibody-RL13-Immunohistochemistry-NB120-2737-img0006.jpg)
![Immunohistochemistry-Paraffin: LAP1 Antibody (RL13) [NB120-2737] - Immunohistochemistry was performed on rat colon tissue. To expose target protein, antigen was retreived. Endogenous peroxidases were blocked in 3% H202-methanol for 15 minutes and tissues were blocked in 3% BSA-PBS for 30 minutes at room temperature. Cells were probed with a LAP1 mouse monoclonal antibody at a dilution of 1:20 overnight in a humidified chamber. Tissues were washed in PBST and detection was performed. DAB staining buffer was applied and tissues were counterstained with hematoxylin and prepped for mounting.](http://images.novusbio.com/fullsize/LAP1-Antibody-RL13-Immunohistochemistry-Paraffin-NB120-2737-img0007.jpg)
![Western Blot: BATF3 Antibody [NBP2-41296] - Analysis of BATF3 in 293 cell lysate with BATF3 antibody at 0.5 ug/ml in (A) the absence and (B) the presence of blocking peptide.](http://images.novusbio.com/fullsize/BATF3-Antibody-Western-Blot-NBP2-41296-img0002.jpg "Western Blot: BATF3 Antibody [NBP2-41296] - Analysis of BATF3 in 293 cell lysate with BATF3 antibody at 0.5 ug/ml in (A) the absence and (B) the presence of blocking peptide.")
![Immunohistochemistry: BATF3 Antibody [NBP2-41296] - Immunohistochemistry of BATF3 in human kidney tissue with BATF3 antibody at 5 ug/mL.](http://images.novusbio.com/fullsize/BATF3-Antibody-Immunohistochemistry-NBP2-41296-img0003.jpg)
![Immunofluorescence: BATF3 Antibody [NBP2-41296] - Immunofluorescence of BATF3 in human kidney tissue with BATF3 Antibody at 20 ug/mL.](http://images.novusbio.com/fullsize/BATF3-Antibody-Immunofluorescence-NBP2-41296-img0004.jpg)
![Immunocytochemistry/ Immunofluorescence: BATF3 Antibody - BSA Free [NBP2-41296] - Immunofluorescence of BATF3 in human kidney tissue with BATF3 Antibody at 20 u/mL.](http://images.novusbio.com/fullsize/nbp2-41296_rabbit-polyclonal-batf3-antibody-2711202419313277.gif)
![Immunohistochemistry: BATF3 Antibody - BSA Free [NBP2-41296] - Immunohistochemistry of BATF3 in human kidney tissue with BATF3 antibody at 5 u/mL.](http://images.novusbio.com/fullsize/nbp2-41296_rabbit-polyclonal-batf3-antibody-2711202420285889.gif)
![Immunohistochemistry: BATF3 Antibody - BSA Free [NBP2-41296] - Immunohistochemistry of BATF3 in human kidney tissue with BATF3 antibody at 5 u/mL.](http://images.novusbio.com/fullsize/nbp2-41296_rabbit-polyclonal-batf3-antibody-2711202419201566.gif)
![Immunocytochemistry/ Immunofluorescence: BATF3 Antibody - BSA Free [NBP2-41296] - Immunofluorescence of BATF3 in human kidney tissue with BATF3 Antibody at 20 u/mL.](http://images.novusbio.com/fullsize/nbp2-41296_rabbit-polyclonal-batf3-antibody-2711202419172279.gif)
![ELISA: Human C1q ELISA Kit (Colorimetric) [NBP2-60617] - Standard Curve](http://images.novusbio.com/fullsize/Human-C1q-ELISA-Kit-Colorimetric-ELISA-NBP2-60617-img0002.jpg "ELISA: Human C1q ELISA Kit (Colorimetric) [NBP2-60617] - Standard Curve")
![Western Blot: proBNP Antibody (50E1) [NB200-440] - Analysis using the Biotin conjugate of NB200-440. Detection of synthetic huBNP in WB after Tricine-SDS-PAGE in reducing conditions.](http://images.novusbio.com/fullsize/proBNP-Antibody-50E1-Western-Blot-NB200-440-img0006.jpg "Western Blot: proBNP Antibody (50E1) [NB200-440] - Analysis using the Biotin conjugate of NB200-440. Detection of synthetic huBNP in WB after Tricine-SDS-PAGE in reducing conditions.")
![Western Blot: proBNP Antibody (50E1) [NB200-440] - Immunodetection of human synthetic BNP (A), recombinant proBNP (E. coli) (B) and recombinant proBNP (mammalian cell line) (C) in Western blotting by different monoclonal antibodies after Tricine- SDS-PAGE under reducing conditions. A, B. Lanes: 1- MAb 24C511-17, 2- MAb 26E211-22, 3- MAb 2G9, 4- MAb 43B1226-32, 5- MAb 50B726-32, 6- MAb 50E126-32, 7- MAb 57H326-32.](http://images.novusbio.com/fullsize/proBNP-Antibody-50E1-Western-Blot-NB200-440-img0004.jpg)
![Immunoassay: proBNP Antibody (50E1) [NB200-440] - Gel-filtration studies of endogenous proBNP and BNP. BNP immunoreactivity measurements in fractions after proteins from plasma of HF patients were separated by gel-filtration on Superdex Peptide column (GEHealthcare). One representative plasma sample. BNP immunoreactivity was measured by 50E126-32-24C511-17 assay (- -). The first peak corresponds to proBNP, the second corresponds to BNP form.](http://images.novusbio.com/fullsize/proBNP-Antibody-50E1-Immunoassay-NB200-440-img0003.jpg)
![ELISA: Human Complement Factor B ELISA Kit (Colorimetric) [NBP2-60564] - Standard curve.](http://images.novusbio.com/fullsize/Human-Complement-Factor-B-ELISA-Kit-Colorimetric-ELISA-NBP2-60564-img0001.jpg "ELISA: Human Complement Factor B ELISA Kit (Colorimetric) [NBP2-60564] - Standard curve.")
![Western Blot: TLR6 Antibody [NBP1-54336] - Titration: 0.2-1 ug/ml, Positive Control: Jurkat cell lysate.](http://images.novusbio.com/fullsize/TLR6-Antibody-Western-Blot-NBP1-54336-img0005.jpg "Western Blot: TLR6 Antibody [NBP1-54336] - Titration: 0.2-1 ug/ml, Positive Control: Jurkat cell lysate.")
![Immunohistochemistry-Paraffin: TLR6 Antibody [NBP1-54336] - Human kidney Tissue, antibody concentration 4-8ug/ml. Cells with positive label: renal corpuscle cells (indicated with arrows) 400X magnification.](http://images.novusbio.com/fullsize/TLR6-Antibody-Immunohistochemistry-Paraffin-NBP1-54336-img0004.jpg)